Melissa Weber

New research shows oncologists and cardiologists need to develop a consensus on how to monitor and treat heart damage in certain cancer patients.

Adding Avastin (bevacizumab) to standard chemotherapy after surgery failed to extend the time early-stage colon cancer patients were free of recurrence.

For the first time, a test can predict which patients with stage 2 colon cancer are more likely to have a recurrence.

The breast cancer drug Herceptin (trastuzumab) extends survival in certain gastric cancer patients by almost three months, according to a phase III international study.

Taking tamoxifen at the same time as certain drugs that treat depression and hot flashes may reduce the cancer drug’s ability to prevent breast cancer recurrence.

A new class of drugs called PARP inhibitors is getting some serious attention in metastatic triple-negative breast cancers.

Educational campaign launched to help nurses help patients who have treatment-related rash.

A drug temporarily withdrawn from the Food and Drug Administration for approval in non-small cell lung cancer will still likely get the green light when it's resubmitted.

New therapies are making headway in a difficult-to-treat cancer.

A brief from this year's San Antonio Breast Cancer Symposium that discusses several new studies that examine the use of hormone replacement therapies and their effects on breast cancer risk and mortality.

A brief from this year's San Antonio Breast Cancer Symposium discussing what new agents researchers have been testing when treating HER2-positive breast cancer.

A brief from this year's San Antonio Breast Cancer Symposium where research was presented on the benefits that the drug Doxil can provide women who have relapsed after anthracycline treatment.

A brief from this year's San Antonio Breast Cancer Symposium detailing research from the AZURE trial that indicates adding the drug Zometa to chemotherapy before surgery may help to shrink breast tumors by an additional third.